Company Profile

Rua Bioscience

Rua is a New Zealand cannabis pharmaceutical company that is aiming to be a leading producer of cannabinoid derived medicines. The Company was established in 2017 in part to support local economic development in the Tairawhiti (East Coast) region, and is a pioneer in the New Zealand medicinal cannabis sector. It was the first company in New Zealand to obtain a licence to cultivate cannabis for research purposes. Rua will operate in the research, cultivation, extraction and manufacturing parts of the medicinal cannabis supply chain.


Announcements
Title Date Type
Rua Launches its First Medicine in New Zealand. Tue, Apr 19 2022 09:30 am GENERAL
SPH Notice - HEL in Rua Bioscience Ltd Fri, Mar 18 2022 10:02 am SHINTR
SPH Notice - HBLP & HBGPL in Rua Bioscience Ltd Thu, Mar 17 2022 03:38 pm SHINTR
Ongoing Disclosure Notices - Manu Caddie Thu, Mar 17 2022 03:31 pm SHINTR
Rua Bioscience Shareholder Newsletter March 2022 Fri, Mar 04 2022 12:00 pm GENERAL
Rua Bioscience Half Year Results Fri, Feb 25 2022 09:01 am HALFYR
Capital Change Notice - Performance Shares Fri, Feb 04 2022 03:42 pm SECISSUE
Capital Change Notice - Ordinary Shares Fri, Feb 04 2022 03:41 pm SECISSUE
Pharmaceutical Giant Acquires Nimbus Health Fri, Feb 04 2022 10:15 am GENERAL
Rua’s Australian Supplier, Cann Group, Receives GMP Tue, Jan 25 2022 04:06 pm GENERAL
Directors and Executives
Trevor Burt
Independent Chairman
Panapa Ehau
Executive Director
Brett Gamble
Non-Executive Director
Rob Mitchell
Chief Executive Officer
Paul Naske
Chief Operating Officer
Martin Smith
Non-Executive Director
Anna Stove
Independent Director
Hamish White
Chief Financial Officer
Company Details
Registered Office: 1 Commerce Place, Awapuni, Gisborne 4071
Postal Address: 1 Commerce Place, Awapuni, Gisborne 4071
Telephone: +64-6-390-6938
Facsimile: n/a
Website: www.ruabio.com
First Listed: 22/10/2020
Balance Date: 30 June
AGM: 19/10/2021
Major Holdings Announcements
Date Name No. Held % Current
18/03/22 Hikurangi Enterprises Limited 8,132,620 - 5.43
17/03/22 Hikurangi Bioactives Limited Partne 4,000,000 12.58 2.67
22/10/20 Fang Group Investment Limited and F 23,584,939 - 16.85
22/10/20 Tailorspace Capital Limited, Tailor 11,129,375 - 7.95
22/10/20 Andrew Charles Williams 7,756,838 - 5.54
Director’s Interests Announcements
Date Name No. Held % Details Other
02/11/21 Hamish White 320,154 - - -
02/11/21 Panapa Ehau 474,224 - - -
02/11/21 Rob Mitchell 288,251 - - -
02/11/21 Paul Naske 159,872 - - -
02/11/21 Trevor Burt 958,002 - - -
22/10/20 Martin Smith 2,544,732 - - -
22/10/20 Brett Gamble 1,805,914 - - -
22/10/20 Anna Stove 763,896 - - -
Analysts’ Forecasts
No forecasts available
Disclaimer
Data on this page is from BusinessDesk and NZX Ltd for information purposes only. Details are believed to be accurate but no warranty is given as to accuracy, timeliness, reliability or completeness. No person should rely on the contents of the report and all persons should obtain independent professional advice before acting on any information connected with or contained in this report.
Last Updated: 04/02/2022
Opinion FREE
Brian Gaynor: a personal obituary
Pattrick Smellie | Mon, 16 May 2022

One of NZ's investment market legends, Brian Gaynor, has died. BusinessDesk managing editor Pattrick Smellie remembers a career-long contact who became a late-career mentor.

Infrastructure
Steel & Tube annual operating profit to be up more than 69%
Jenny Ruth | Mon, 16 May 2022

While Steel & Tube's revenue was up 25% in the 10 months ended April on the same months a year earlier, volumes were up just 8%.

Markets FREE
Milford co-founder, BusinessDesk backer Brian Gaynor dies
Staff reporters | Mon, 16 May 2022

One of the greats of the NZ investment world, Brian Gaynor was instrumental in revitalising BusinessDesk.